Advertisement
Document › Details
Consilium Strategic Communications Ltd.. (11/12/18). "Press Release: Alex Harrison Joins Consilium Strategic Communications". London.
Consilium Strategic Communications, a global leader in strategic healthcare investor relations and communications, today announces the appointment of Alex Harrison as a Senior Advisor.
Alex is a healthcare communications specialist with more than 15 years’ experience working in-house in strategic communications at both GSK and Cadbury and prior to that at Brunswick. Alex has also worked within the patient group, The Brain Tumour Charity, advising on communications. She has experience in developing and delivering successful corporate communication, corporate responsibility and employee engagement strategies.
“I am very pleased to welcome Alex as a Senior Advisor to the growing team at Consilium. With her proven track record we are pleased that she joins us with significant corporate PR expertise which complements our global strategic communications and IR offering.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
“I am thrilled to be able to support clients at the ever-growing Consilium Strategic Communications. Consilium’s offering is unique and praised internationally for the quality of its capital markets advice and execution, resulting in an exceptional healthcare client base.”
Alex Harrison
Alexandra Harrison can be contacted on +44 (0)20 3709 5700 and harrison@consilium-comms.com.
For more information please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Chris Gardner
Tel: +44(0)20 3709 5700
info@consilium-comms.com/
www.consilium-comms.com
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.
Record changed: 2023-06-05 |
Advertisement
More documents for ICR (Group)
- [1] ICR Inc.. (9/12/23). "Press Release: ICR Acquires Consilium Strategic Communications, Creating Global Leader in Healthcare Communications and Investor Relations". New York, NY....
- [2] Consilium Strategic Communications Ltd.. (2/20/23). "Press Release: Consilium Strategic Communications Expands International Presence in US and Europe with Two Senior Strategic Advisor Appointments". London....
- [3] Consilium Strategic Communications Ltd.. (5/6/22). "Press Release: Consilium Strategic Communications Appoints Tracy Cheung as Partner". London....
- [4] OMass Therapeutics Ltd.. (4/28/22). "Press Release: OMass Therapeutics Raises $100 Million in Series B Financing to Progress Drug Pipeline in Immunology and Rare Diseases". Oxford....
- [5] Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon....
- [6] Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London....
- [7] Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London....
- [8] Oasmia Pharmaceutical AB. (8/10/20). "Press Release: Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer". Uppsala....
- [9] Consilium Strategic Communications Ltd.. (9/26/19). "Press Release: Consilium Strategic Communications Expands International Senior Team with Four New Appointments". London & Boston, MA....
- [10] Ascendis Pharma A/S. (8/28/19). "Press Release: Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top